United States · FDA National Drug Code directory
Levothyroxine sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87063-086_4a23a284-a6e2-10db-e063-6394a90a11cc
- Product NDC
- 87063-086
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- ASCLEMED USA INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201125
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 88 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (87063-086-00) · 87063-086-00
- 30 TABLET in 1 BOTTLE (87063-086-30) · 87063-086-30
- 60 TABLET in 1 BOTTLE (87063-086-60) · 87063-086-60
- 90 TABLET in 1 BOTTLE (87063-086-90) · 87063-086-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →